Cargando…
Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9–14 Years Versus a 3-Dose Regimen in Women Aged 15–25 Years
Background. This randomized, open trial compared regimens including 2 doses (2D) of human papillomavirus (HPV) 16/18 AS04-adjuvanted vaccine in girls aged 9–14 years with one including 3 doses (3D) in women aged 15–25 years. Methods. Girls aged 9–14 years were randomized to receive 2D at months 0 an...
Autores principales: | Puthanakit, Thanyawee, Huang, Li-Min, Chiu, Cheng-Hsun, Tang, Ren-Bin, Schwarz, Tino F., Esposito, Susanna, Frenette, Louise, Giaquinto, Carlo, McNeil, Shelly, Rheault, Paul, Durando, Paolo, Horn, Michael, Klar, Maximilian, Poncelet, Sylviane, De Simoni, Stéphanie, Friel, Damien, De Muynck, Benoit, Suryakiran, Pemmaraju V., Hezareh, Marjan, Descamps, Dominique, Thomas, Florence, Struyf, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957434/ https://www.ncbi.nlm.nih.gov/pubmed/26908726 http://dx.doi.org/10.1093/infdis/jiw036 |
Ejemplares similares
-
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9–14 Years: A Randomized Trial
por: Huang, Li-Min, et al.
Publicado: (2017) -
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial
por: Leung, Ting Fan, et al.
Publicado: (2015) -
Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age
por: Schwarz, Tino F., et al.
Publicado: (2017) -
Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen
por: Aurpibul, Linda, et al.
Publicado: (2019) -
Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger
por: Hui, Shuk Yi Annie, et al.
Publicado: (2017)